Details

Autor(en) / Beteiligte

• The Lancet Editors

Titel

Retraction—Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

Ist Teil von

• The Lancet (British edition), 2013-09, Vol.382 (9895), p.843-843

Ort / Verlag

England: Elsevier Ltd

Erscheinungsjahr

2013

Link zum Volltext

Quelle

Elsevier ScienceDirect Journals Complete

Beschreibungen/Notizen

• In April of this year, The Lancet received a letter from a professor at Osaka City University Graduate School of Medicine informing us that there has never been a Department of Clinical Epidemiology in the university, that Osaka City University "has never had the statistical analysis group for Jikei Heart Study", and that Mr Shirahashi "has never been staff of our university" but was employed by Novartis Pharma Japan. Dr Azam also told us: "In addition, it appears Mr Shirahashi obtained an unpaid position in about 2001 with the Osaka City University Graduate School's Medical Research Faculty as a part-time lecturer in the Department of Medicine.